The global Specialty PACS Market was valued at USD 3.21 billion in 2023 and is projected to reach USD 5.21 billion by 2032, growing at a CAGR of 5.56% during the forecast period. This growth is driven by rising chronic disease prevalence, increased adoption of AI in diagnostic imaging, and the demand for specialty-specific PACS solutions in radiology, cardiology, oncology, and ophthalmology. Cloud-based PACS deployment, interoperability advancements, and improved workflow efficiency further boost market expansion. North America leads in market share, while Asia Pacific shows the fastest growth due to expanding healthcare infrastructure.